...
首页> 外文期刊>Biochemical Pharmacology >Suppression of RelA/p65 transactivation activity by a lignoid manassantin isolated from Saururus chinensis.
【24h】

Suppression of RelA/p65 transactivation activity by a lignoid manassantin isolated from Saururus chinensis.

机译:分离自中国金龙的木质素manassantin抑制RelA / p65反式激活活性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In our search for NF-kappaB inhibitors from natural resources, we have previously identified two structurally related dilignans, manassantin A and B as specific inhibitors of NF-kappaB activation from Saururus chinensis. However, their molecular mechanism of action remains unclear. We here demonstrate that manassantins A and B are potent inhibitors of NF-kappaB activation by the suppression of transciptional activity of RelA/p65 subunit of NF-kappaB. These compounds significantly inhibited the induced expression of NF-kappaB reporter gene by LPS or TNF-alpha in a dose-dependent manner. However, these compounds did not prevent the DNA-binding activity of NF-kappaB assessed by electrophoretic mobility shift assay as well as the induced-degradation of IkappaB-alpha protein by LPS or TNF-alpha. Further analysis revealed that manassantins A and B dose-dependently suppressed not only the induced NF-kappaB activation by overexpression of RelA/p65, but also transactivation activity of RelA/p65. Furthermore, treatment of cells with these compounds prevented the TNF-alpha-induced expression of anti-apoptotic NF-kappaB target genes Bfl-1/A1, a prosurvival Bcl-2 homologue, and resulted in sensitizing HT-1080 cells to TNF-alpha-induced cell death. Similarly, these compounds also suppressed the LPS-induced inducible nitric oxide synthase expression and nitric oxide production. Taken together, manassantins A and B could be valuable candidate for the intervention of NF-kappaB-dependent pathological condition such as inflammation and cancer.
机译:在我们从自然资源中寻找NF-kappaB抑制剂的过程中,我们先前已经确定了两种结构上相关的木酚素,即金刚烷素A和B,它们是中国金龙的NF-kappaB活化的特异性抑制剂。但是,它们的作用机理尚不清楚。我们在这里证明,通过抑制NF-kappaB的RelA / p65亚基的转录活性,manassantins A和B是有效的NF-kappaB激活抑制剂。这些化合物以剂量依赖的方式显着抑制LPS或TNF-α诱导的NF-κB报告基因表达。但是,这些化合物不能阻止通过电泳迁移率迁移分析评估的NF-κB的DNA结合活性,也不能阻止LPS或TNF-α对Ikappa-α蛋白的诱导降解。进一步的分析表明,Manassantins A和B不仅剂量依赖性地抑制RelA / p65的过表达诱导的NF-κB活化,而且还抑制RelA / p65的反式激活活性。此外,用这些化合物处理细胞可阻止TNF-α诱导的抗凋亡NF-kappaB靶基因Bfl-1 / A1(一种存活的Bcl-2同源物)的表达,并导致HT-1080细胞对TNF-α敏感诱导的细胞死亡。同样,这些化合物也抑制LPS诱导的一氧化氮合酶的表达和一氧化氮的产生。两者合计,manassantins A和B可能是干预NF-kappaB依赖的病理性疾病(例如炎症和癌症)的有价值的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号